Oxford Asset Management’s Amedisys AMED Stock Holding History

Oxford Asset Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-8,163	Closed	-$803K	–	444
2025 Q2	$803K	Buy	+8,163	New	+$772K	0.27%	90
2024 Q4	–	Sell	-3,505	Closed	-$338K	–	448
2024 Q3	$338K	Buy	+3,505	New	+$342K	0.28%	144
2019 Q2	–	Sell	-19,339	Closed	-$2.38M	–	1682
2019 Q1	$2.38M	Buy	19,339 +12,728	+193%	+$1.6M	0.05%	495
2018 Q4	$774K	Sell	6,611 -1,221	-16%	-$144K	0.02%	985
2018 Q3	$957K	Buy	+7,832	New	+$865K	0.02%	1030
2018 Q2	–	Sell	-11,185	Closed	-$675K	–	1680
2018 Q1	$675K	Sell	11,185 -11,258	-50%	-$641K	0.01%	1117
2017 Q4	$1.18M	Sell	22,443 -18,168	-45%	-$957K	0.03%	850
2017 Q3	$2.27M	Buy	40,611 +4,784	+13%	+$253K	0.04%	560
2017 Q2	$2.25M	Buy	+35,827	New	+$2.09M	0.04%	549
2016 Q4	–	Sell	-60,472	Closed	-$2.87M	–	759
2016 Q3	$2.87M	Sell	60,472 -16,151	-21%	-$806K	0.09%	311
2016 Q2	$3.87M	Sell	76,623 -55,657	-42%	-$2.81M	0.13%	210
2016 Q1	$6.39M	Buy	132,280 +27,126	+26%	+$1.05M	0.18%	121
2015 Q4	$4.14M	Sell	105,154 -42,892	-29%	-$1.72M	0.1%	226
2015 Q3	$5.62M	Buy	148,046 +116,050	+363%	+$4.89M	0.18%	107
2015 Q2	$1.27M	Buy	+31,996	New	+$997K	0.03%	417
2014 Q4	–	Sell	-120,786	Closed	-$2.46M	–	705
2014 Q3	$2.46M	Sell	120,786 -109,699	-48%	-$2.12M	0.06%	330
2014 Q2	$3.89M	Buy	+230,485	New	+$3.27M	0.13%	229
2013 Q4	–	Sell	-220,764	Closed	-$3.8M	–	688
2013 Q3	$3.8M	Buy	+220,764	New	+$3.27M	0.08%	303

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Oxford Asset Management's AMED Position: Q3 2025 in Review

Oxford Asset Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 8,163 shares — an estimated $803K sold.

Oxford Asset Management first reported a position in AMED in Q3 2013 and held it in 18 quarters. The position peaked at $6.39M in Q1 2016. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

Oxford Asset Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
Oxford Asset Management sold 8,163 Amedisys shares in Q3 2025, an estimated $803K.
Oxford Asset Management first reported a position in Amedisys in Q3 2013 and held it in 18 quarters.
Oxford Asset Management's Amedisys position peaked at $6.39M in Q1 2016.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Oxford Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.